sanofi pasteur — The vaccines business of sanofi-aventis Group
Protect
VaccinePlace.com -- Search.  Know more.
Explore Protect Learn

[BACK]

Image of the Fluzone Influenza logo

For Health-Care Professionals

Influenza prevention is an important public health concern, and it should be a high priority for everyone involved in clinical practice. This section of Fluzone.com is designed for you, the health-care professional. It will provide you with information and tools to help make influenza prevention a routine part of your practice all year long.

At Fluzone.com for health-care professionals, you can:

  • Obtain coding and reimbursement information
  • Download educational materials
  • Order Fluzone vaccine
Click on the circles below to access the information you need.
Follow this link fo rpatient and parent education materials Follow this link fo rfluzone vaccine dosing guidelines Follow this link for coding and reimbursement information

 

Indication
Fluzone vaccine is indicated for active immunization in persons 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

Safety Information
The most common local and systemic adverse reactions to Fluzone vaccine include soreness, pain, and swelling at the vaccination site; fever, malaise, and myalgia. Other adverse reactions may occur. Influenza vaccine should not be administered to anyone with a history of hypersensitivity to any vaccine component, including eggs, egg products, or thimerosal (the only presentation that contains thimerosal is the multi-dose vial). Fluzone vaccine should not be administered to individuals who have a prior history of Guillain-Barré syndrome (GBS). Vaccination with Fluzone vaccine may not protect all individuals.
 
Before administering Fluzone vaccine, please see accompanying full Prescribing Information.

[BACK]

Provided as a service by Sanofi Pasteur Inc.
Copyright © 2010 Sanofi Pasteur Inc.
This page last updated: 13-Aug-2010